RepSox

1,5-Naphthyridine, 2-[3-(6-methyl-2-pyridinyl)-1H-pyrazol-4-yl]-

1,5-naphthyridine, 2-[5-(6-methyl-2-pyridinyl)-1H-pyrazol-4-yl]-

2-(3-(6-Methylpyridin-2-yl)-1H-pyrazol-4-yl)-1,5-naphthyridine

2-[3-(6-Methyl-2-pyridinyl)-1H-pyrazol-4-yl]-1,5-naphthyridin

2-[3-(6-Methyl-2-pyridinyl)-1H-pyrazol-4-yl]-1,5-naphthyridine

2-[3-(6-Méthyl-2-pyridinyl)-1H-pyrazol-4-yl]-1,5-naphtyridine

2-[3-(6-Methylpyridin-2-yl)-1H-pyrazol-4-yl]-1,5-naphthyridine

2-[5-(6-methylpyridin-2-yl)-1H-pyrazol-4-yl]-1,5-naphthyridine

446859-33-2

ALK5 Inhibitor II

MFCD09037561

RepSox

2-(3-(6-Methylpyridine-2-yl)-1H-pyrazol-4-yl)-1,5-naphthyridine

2-(5-(6-methylpyridin-2-yl)-1H-pyrazol-4-yl)-1,5-naphthyridine

2-[3-(6-Methyl-pyridin-2-yl)-1H-pyrazol-4-yl]-[1,5]naphthyridine

2-[3-(6-METHYLPYRIDIN-2-YL)-2H-PYRAZOL-4-YL]-1,5-NAPHTHYRIDINE

2-[5-(6-METHYLPYRIDIN-2-YL)-2,3-DIHYDRO-1H-PYRAZOL-4-YL]-1,5-NAPHTHYRIDINE

alk 5 inhibitor ii

ALK5 Inhibitor

ALK5 Inhibitor II and TGF-β RI Kinase Inhibitor II

ALK5 Inhibitor II, Transforming Growth Factor-β Type I Receptor Kinase Inhibitor II, 2-(3-(6-Methylpyridin-2-yl)-1H-pyrazol-4-yl)-1,5-naphthyridine

E-616452;SJN 2511;E616452;SJN2511;E 616452;SJN-2511

E-616452;SJN 2511;E616452;SJN2511;E 616452;SJN-2511,ALK5 Inhibitor II

GW786460X

GW786460X (616452)

RepSox (ALK5 Inhibitor II)

RepSox (E-616452)

repsox(alk5 inhibitor ii)

repsox(e-616452; sjn 2511)

TGF-β receptor type-1

TGFR1_HUMAN